Thyroid dysfunction: An autoimmune aspect

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 5, 2015, Pages 6677-6681

  Khan, Farah Aziz ^a   Al Jameil, Noura ^a   Khan, Mohammad Fareed ^a   Al Rashid, May ^a   Tabassum, Hajera ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antibody; Autoimmunity; Cytokines; Lymphocytes; Thyroglobulin; Thyroid peroxidase

Indexed keywords

GADOLINIUM; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; PROSTAGLANDIN; THYROGLOBULIN; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INFLAMMATION; REVIEW; T LYMPHOCYTE; THYROID FOLLICLE CELL; THYROID GLAND;

EID: 84937022298     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. [1] Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977; 7: 481-93.
2. [2] Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43: 55-68.
3. [3] Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012; 379: 1142-1154.
4. [4] Franklyn JA. The Thyroid-too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clin Endocrinol 2013; 78: 1-8.
5. [5] Collins J, Gough S. Autoimmunity in thyroid disease. Eur J Nucl Med Mol Imaging 2002; 29: 417-424.
6. [6] Crivellato E, Vacca A, Ribatti D. Setting the stage: an anatomist’s viewof the immune system. Trends Immunol 2004; 25: 210-217.
7. [7] Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008; 30: 58-62.
8. [8] Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA et al. Serum TSH, T(4), and thyroid antibodies in the United States population 1988 to 1994: National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499.
9. [9] Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003; 148: 1-9.
10. [10] Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity from epidemiology to etiology. J Autoimmun 2008; 30: 58-62.
11. [11] Sakaguchi S, Yamaguchi T, Nomura T. Regulatory T cells and immunetolerance. Cell 2008; 133: 775-787.
12. [12] Shevach EM. Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000; 18: 423-449.
13. [13] Prasad KV, Prabhakar BS. Apoptosis and autoimmunedisorders. Autoimmunity 2003; 36: 323-330.
14. [14] Weaver CT, Harrington LE, Mangan PR, Paul RM, Maya G, Kenneth MM. Th17: an effector CD T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-688.
15. [15] Wang SH, Baker JR. The role of apoptosis in thyroid autoimmunity. Thyroid 2007; 17: 975-979.
16. [16] Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, Richiusa P, Galluzzo A, Giordano C. Regulation of apoptosisin endocrine autoimmunity: insights from Hashimoto’s thyroiditisand Graves’ disease. Ann N Y Acad Sci 2002; 966: 496-501.
17. [17] Hanna M, Marcin M, Monika OM, Marek N. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endocrin Polska 2014; 65: 150-155.
18. [18] Andrew GG, Nicole K, Terry JS. Cytokines, Graves’ Disease, and Thyroid-Associated Ophthalmopathy. Thyroid 2008; 18: 953-958.
19. [19] Nanba T, Watanabe M, Inoue N. Increases of the Th1/Th2 cell ratioin severe Hashimoto’s disease and in the proportion of Th17 cells inintractable Graves’ disease. Thyroid 2009; 19: 499-501.
20. [20] Nagayama Y. Graves’ animal models of Graves’ hyperthyroidism. Thyroid 2007; 17: 981-988.
21. [21] Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González-Amaro R, Marazuela M. Increased circulatingpro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. J Clin Endocrinol Metab 2010; 95: 953-962.
22. [22] Nielsen CH, Hegedüs L, Leslie RG. Auto-antibodies in autoimmune thyroid diseasepromote immune complex formation with self-antigens and increase B cell and CD4+ T cellproliferation in response to self-antigens. Eur J Immunol 2004; 34: 263-272.
23. [23] Burek CL, Rose NR. Thyroglobulin antibodies. In: Peter JB and Schonfeld Y, editors. Autoantibodies. New York: Elsevier; 1996. pp. 810-815.
24. [24] Vasileiadis I, Georgios B, Georgios C, Eleni K, Theodore K. Thyroglobulin Antibodies Could be a Potential Predictive Marker for Papillary Thyroid Carcinoma Endocrinology. Ann Surg Oncol 2014; 21: 2725-273.
25. [25] McLachlan SM, Rapoport B. The molecular biology ofthyroid peroxidase: cloning, expression and role as autoantigenin autoimmune thyroid disease. Endocrine Rev 1992; 13: 192-206.
26. [26] Mehran L, Tohidi M, Sarvghadi F, Delshad H, Amouzegar A, Soldin OP. Management of thyroid peroxidase antibody euthyroid womenin pregnancy: comparison of the american thyroid associationand the endocrine society guidelines. J Thyroid Res Volume 2013; 2013: 542-692.
27. [27] Green AS, Roman SH, Cobin RH, Harazy E, Marfany AA, Davies TF. Detection of at-riskpregnancy by means of highly sensitive assays for thyroidautoantibodies. J Am Med Asso 1990; 264: 1422-1425.
28. [28] Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endo 2004; 150: 751-755.
29. [29] Glinoer D, Soto MF, Bourdoux P. Pregnancy in patientswith mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endo Metab 1991; 73: 421-427.
30. [30] Green AS, Glinoer D. Thyroid autoimmunity andthe risk of miscarriage. Best Prac Res 2004; 18: 167-181.
31. [31] Poppe K, Velkeniers B, Glinoer D. The role of thyroidautoimmunity in fertility and pregnancy. Nature Clin Prac Endocrin Metab 2008; 4: 394-405.
32. [32] Njemini R, Meyers I, Demanet C, Smitz J, Sosso M, Mets T. The prevalence of autoantibodies in an elderlysub-Saharan African population. Clin Exp Immun 2002; 127: 99-106.
33. [33] Silva LM, Chavez J, Canalli MH, Zanetti CR. Determinationof IgG subclasses and avidity of antithyroid peroxidaseantibodies in patients-with subclinical hypothyroidism-a comparisonwith patients with overt hypothyroidism. Horm Res 2003; 59: 118-24.
34. [34] Kim CH. Chemokine-chemokine receptor network in immune cell trafficking. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4: 343-361.
35. [35] Boelaert K, Franklyn JA. Thyroid hormone in health anddisease. J Endocrin 2005; 187: 1-15.
36. [36] Prabhakar BS, Fan J, Seetharamaiah GS. Thyrotropinreceptor-mediated diseases: a paradigm for receptor autoimmunity. Immunology Today 1997; 18: 437-442.
37. [37] Gianoukakis, Khadavi N, Terry JS, Gianoukakis AG, Smith TJ. The role of cytokines inthe pathogenesis of endocrine disease. Canad Diab J 2004; 28: 20-29.
38. [38] Rasmussen AK. Cytokine actions on the thyroid gland. Dan Med Bull 2000; 47: 94-101.
39. [39] Ajjan RA, Watson PF, Weetman AP. Cytokines andthyroid function. Adv Neuroimmunol 1996; 6: 359-386.
40. [40] Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. Role of Cytokines in the Pathogenesis and Suppression of Thyroid Autoimmunity. J Interferon Cytokine Res 2011; 31: 721-31.
41. [41] Pedro AB, Romaldini JH, Takei K. Changes of serum cytokines in hyperthyroid Graves’ disease patients at diagnosis and during methimazole treatment. Neuro immunomodulation 2011; 18: 45-51.
42. [42] Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000; 1: 199-205.
43. [43] Batteux F, Trebeden H, Charreire J, Chiocchia G. Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10. Eur J Immunol 1999; 29: 958-963.
44. [44] Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448: 484-487.
45. [45] Horie I, Abiru N, Nagayama Y, Kuriya G, Saitoh O, Ichikawa T. T helper type 17 immune response plays an indispensable role for development of iodine induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. Endocrin 2009; 150: 5135-5142.
46. [46] Natt N, Bahn RS. Cytokines in the evolution of Graves’ ophthalmopathy. Autoimmunity 1997; 26: 129-136.
47. [47] Hunt PJ, Marshall SE, Weetman AP. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 1984-1988.